Table 4.
Comparison of fatty acid profiles of the HFD group and HFD + EPA + L-carnitine group.
| Annotation | Average HFD | Average HFD + Car + EPA | Ratio (HFD + Car + EPA/HFD) | p-value |
|---|---|---|---|---|
| myristate;14:0 | 39864 | 45495 | 1.14 | 0.3747 |
| pentadecanoate;15:0 | 12806 | 12022 | 0.94 | 0.3970 |
| palmitoleate;(Z)16:1n-7 | 40622 | 40597 | 1.00 | 0.9954 |
| palmitate;16:0 | 938375 | 835335 | 0.89 | 0.0956 |
| margarate;17:0 | 19084 | 16310 | 0.85 | 0.1440 |
| ganma-linolenate;(Z)18:3n-6 | 20128 | 12878 | 0.64 | 0.0970 |
| linoleate;(Z)18:2n-6 | 129876 | 120579 | 0.93 | 0.6941 |
| petroselate;(Z)18:1n-12 | 2211886 | 2192572 | 0.99 | 0.9155 |
| oleate;(Z)18:1n-9 | 454157 | 436289 | 0.96 | 0.6564 |
| elaidate;(E)18:1n-9 | 38177 | 42735 | 1.12 | 0.0929 |
| cis-12-Octadecenoate;(Z)18:1n-6 | 38177 | 42735 | 1.12 | 0.0929 |
| stearate;18:0 | 318521 | 280405 | 0.88 | 0.1704 |
| nonadecanoate;19:0 | 12130 | 11668 | 0.96 | 0.3738 |
| arachidonate;(Z)20:4n-6 | 28383 | 17889 | 0.63 | 0.0010 |
| cis-5,8,11,14,17-Eicosapentaenoate;(Z)20:5n-3 | n.a. | 2079 | n.a. | n.a. |
| eicosa-8,11,14-trienoate;20:3n-6 | 7323 | 7257 | 0.99 | 0.9544 |
| cis-11,14-Icosadienoate;(Z)20:2n-6 | 2134 | 2610 | 1.22 | 0.3270 |
| cis-11-icosenoate;(Z)20:1n-9 | 58754 | 82056 | 1.40 | 0.0375 |
| arachisate;20:0 | 5012 | 6328 | 1.26 | 0.2704 |
| cis-4,7,10,13,16,19-Docosahexaenoate;(Z)22:6n-3 | 18472 | 48002 | 2.60 | 0.0001 |
| cis-7,10,13,16,19-docosapentaenoate;(Z)22:5n-3 | 7977 | 16180 | 2.03 | 0.0021 |
The relative areas of the peaks are shown. The ratio represents the values for the HFD + EPA + L-carnitine group to the values for the HFD group. A significant difference (p < 0.05) or (p < 0.01) is shown by one underline or two underlines. The ratio column is indicated by font that is underlined (increased; p < 0.05), bold (increased; p < 0.01), italic and underlined (decreased; p < 0.05) and italic and bold (decreased; p < 0.01). n.d.: not detected, n.a.: not available.